23-valent pneumococcal polysaccharide vaccine against pneumococcal pneumonia.

Motoi Suzuki, Bhim Gopal Dhoubhadel, Shungo Katoh, Koya Ariyoshi, Konosuke Morimoto
Author Information
  1. Motoi Suzuki: Department of Clinical Medicine, Institute of Tropical Medicine, Nagasaki University, Nagasaki 852-8523, Japan.
  2. Bhim Gopal Dhoubhadel: School of Tropical Medicine and Global Health, Nagasaki University, Nagasaki, Japan.
  3. Shungo Katoh: Department of Clinical Medicine, Institute of Tropical Medicine, Nagasaki University, Nagasaki 852-8523, Japan.
  4. Koya Ariyoshi: Department of Clinical Medicine, Institute of Tropical Medicine, Nagasaki University, Nagasaki 852-8523, Japan.
  5. Konosuke Morimoto: Department of Clinical Medicine, Institute of Tropical Medicine, Nagasaki University, Nagasaki 852-8523, Japan. Electronic address: komorimo@nagasaki-u.ac.jp.

Abstract

No abstract text available.

MeSH Term

Humans
Pneumococcal Infections
Pneumococcal Vaccines
Pneumonia, Pneumococcal
Streptococcus pneumoniae

Chemicals

Pneumococcal Vaccines

Word Cloud

Created with Highcharts 10.0.0pneumococcal23-valentpolysaccharidevaccinepneumonia

Similar Articles

Cited By